Artemisinins: Activities and actions

Richard K. Haynes; Sanjeev Krishna

doi:10.1016/j.micinf.2004.09.002

Artemisinins: Activities and actions

Richard K. Haynes
, Sanjeev Krishna

Department of Chemistry

Research output: Contribution to journal › Short survey › peer-review

99 Citations (Scopus)

Abstract

Multidrug-resistant malaria caused by Plasmodium falciparum has severely limited treatment options over recent years. Artemisinins are still effective for treating uncomplicated as well as severe malaria, because resistance is not yet clinically apparent. This article reviews some clinically useful properties of artemisinins and how they might work.

Original language	English
Pages (from-to)	1339-1346
Number of pages	8
Journal	Microbes and Infection
Volume	6
Issue number	14
DOIs	https://doi.org/10.1016/j.micinf.2004.09.002
Publication status	Published - Nov 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Artemisinin
Malaria
Multidrug-resistance

Access to Document

10.1016/j.micinf.2004.09.002

Cite this

@article{823c8fbfc1ff453b938fd7fb94a617a1,

title = "Artemisinins: Activities and actions",

abstract = "Multidrug-resistant malaria caused by Plasmodium falciparum has severely limited treatment options over recent years. Artemisinins are still effective for treating uncomplicated as well as severe malaria, because resistance is not yet clinically apparent. This article reviews some clinically useful properties of artemisinins and how they might work.",

keywords = "Artemisinin, Malaria, Multidrug-resistance",

author = "Haynes, \{Richard K.\} and Sanjeev Krishna",

year = "2004",

month = nov,

doi = "10.1016/j.micinf.2004.09.002",

language = "English",

volume = "6",

pages = "1339--1346",

journal = "Microbes and Infection",

issn = "1286-4579",

publisher = "Elsevier Masson s.r.l.",

number = "14",

}

TY - JOUR

T1 - Artemisinins

T2 - Activities and actions

AU - Haynes, Richard K.

AU - Krishna, Sanjeev

PY - 2004/11

Y1 - 2004/11

N2 - Multidrug-resistant malaria caused by Plasmodium falciparum has severely limited treatment options over recent years. Artemisinins are still effective for treating uncomplicated as well as severe malaria, because resistance is not yet clinically apparent. This article reviews some clinically useful properties of artemisinins and how they might work.

AB - Multidrug-resistant malaria caused by Plasmodium falciparum has severely limited treatment options over recent years. Artemisinins are still effective for treating uncomplicated as well as severe malaria, because resistance is not yet clinically apparent. This article reviews some clinically useful properties of artemisinins and how they might work.

KW - Artemisinin

KW - Malaria

KW - Multidrug-resistance

UR - https://www.scopus.com/pages/publications/9144247114

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000225499700014

UR - https://openalex.org/W2083001268

U2 - 10.1016/j.micinf.2004.09.002

DO - 10.1016/j.micinf.2004.09.002

M3 - Short survey

SN - 1286-4579

VL - 6

SP - 1339

EP - 1346

JO - Microbes and Infection

JF - Microbes and Infection

IS - 14

ER -

Artemisinins: Activities and actions

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this